Biomedica On The Move 2019
Valorisation in Regenerative Medicine

October 10, 2019

12-18.30 pm

Brightlands Chemelot Campus, Geleen (NL)

Progress in Regenerative Medicine provides opportunities for the entire Euregional ecosystem including biotechnology ánd medical technology SMEs. Novel mechanisms of actions are developed and pushed forward in the value chain, laboratory & handling infrastructure changes and the need to monitor and measure increases.

 

We cordially invite you to attend this very first edition of Biomedica On The Move and benefit from:

  • the chance to meet many potential project or business partners in a short time

  • the ability to discuss your innovation and collaboration needs in more detail during 1-on-1 matchmaking meetings

  • effectively gain knowledge on the Euregional facilities and expertise

Registration is free of cost but without exception mandatory due to site access regulations. The event is almost fully booked!
If you register now, you will be automatically on a waiting list. 

Follow us

  • LinkedIn Social Icon

The Program

12.00

13.00

13.05

13.20

13.45

14.00

14.15

14.30

15.00

16.00

16.15

16.30

16.45

17.00

17.30

18.30

Lunch buffet, Coffee & Tea

Welcome by the chair of the event

Prof. Dr. med. Stefan Jockenhoevel, Applied Medical Engineering, Helmholtz Institute Aachen

Opening
Creating impact in healthcare by combining research, expertise of the industry and input of patients
Carmen Van Vilsteren, Director Strategic Area Health of Eindhoven University of Technology (TU/e) and Chair of the Topsector Life Sciences & Health

Keynote lecture
Progress & Future in Regenerative Medicine
Kurt Gielen, Sr. Business Development Manager Brightlands  

Euregional Company Pitches, Block 1

Achieving increased efficacy and yield of stem cells, Dr. Van den Bos, CEO, Mares Ltd, Germany

Hidden benefits of workflow automation in complex tissue products and assays, T. Carden, CEO, Nestegg Biotech BV, The Netherlands

Organoid technology: promising strategy for regenerative medicine, E. Jans/ K. Frederix, InnoSer België NV, Belgium

Ex Vivo organ models for effective therapy development, M. Stijnen, CTO, LifetecGroup BV, The Netherlands

1-on-1 Matchmaking

      

Enterprise Europe Network  offers the opportunity to plan targeted and time-efficient meetings with companies and expertise centers from Belgium, Germany, The Netherlands and abroad.

 

Through an online platform, interested parties can present themselves in the run-up to the event with a profile and thus organize targeted appointments at their own discretion.

Already 48 profiles approved and ready for meetings to be booked.

 

Participation is free of charge, registration mandatory.

Euregional Company Pitches, block 2
 

The future is nature – advanced implant solutions from natural silk, Marius Köpf, Aleksander Drinic, and Sandra Fuest
Fibrothelium GmbH, Aachen (DE)


Regenerative technology for Cardiovascular Applications, Andy Forsberg, Director of Operations, Xeltis BV, Eindhoven (NL)

Production of frozen undifferentiated human muscle-derived stem cells for autologous therapeutic use, Revatis, Liege (BE)

EATRIS: Providing research services and expertise to accelerate your ATMP Development, David Morrow, EATRIS, Amsterdam (NL)

Closing lecture
Regenerative medicine valorisation strategies from ecosystem to SME, J. Schrooten. CEO, Antleron NV, Leuven
(BE)

Networking, Matchmaking & Table Presentations 

Closing

 Contact

Annemarie Schrauwen

annemarie@asmarketingnetwork.com

Ingrid Relou (until October 4 only)

Program Manager Cluster LifetecZONe

E: irelou@lifetecZONe.nl

© 2019 Biomedica on the move, all rights reserved 
Design by Brightlands Maastricht Health Campus